Papers
6
Total Citations
243
H-Index
5
About
Davide Citterio is a leading surgical oncologist whose work is redefining the boundaries of minimally invasive liver surgery. His research focuses on the safety, efficacy, and technical challenges of laparoscopic and robotic resections for primary liver malignancies, particularly hepatocellular carcinoma (HCC) and colorectal liver metastases. Citterio’s most impactful contribution is a landmark 2022 study comparing robotic versus open liver resection for HCC, which has garnered 138 citations and provides crucial long-term oncologic outcome data in a field where evidence remains sparse. He has also systematically investigated how liver cirrhosis, portal hypertension, and neoadjuvant chemotherapy affect the difficulty and outcomes of both major and minor minimally invasive resections, producing a series of international multicenter studies in 2023. His early work on laparoscopic and robot-assisted gastrectomy for adenocarcinoma further demonstrates his pioneering role in advanced minimal access techniques. Through rigorous comparative analyses and propensity-score matched studies, Citterio is providing the evidence base needed to safely expand the indications for robotic and laparoscopic liver surgery in complex patient populations.
Research Focus
Key Achievements
Top Papers
- 1
- 2
- 3
- 4
- 5
- 6